University of Leicester
Browse

An International Comparison of Death Classification at 22 to 25 Weeks' Gestational Age

Download (420.89 kB)
journal contribution
posted on 2018-08-13, 14:33 authored by Lucy K. Smith, Naho Morisaki, Nils-Halvdan Morken, Mika Gissler, Paromita Deb-Rinker, Jocelyn Rouleau, Stellan Hakansson, Michael R. Kramer, Michael S. Kramer
OBJECTIVES: To explore international differences in the classification of births at extremely low gestation and the subsequent impact on the calculation of survival rates. METHODS: We used national data on births at 22 to 25 weeks' gestation from the United States (2014; n = 11 144), Canada (2009-2014; n = 5668), the United Kingdom (2014-2015; n = 2992), Norway (2010-2014; n = 409), Finland (2010-2015; n = 348), Sweden (2011-2014; n = 489), and Japan (2014-2015; n = 2288) to compare neonatal survival rates using different denominators: all births, births alive at the onset of labor, live births, live births surviving to 1 hour, and live births surviving to 24 hours. RESULTS: For births at 22 weeks' gestation, neonatal survival rates for which we used live births as the denominator varied from 3.7% to 56.7% among the 7 countries. This variation decreased when the denominator was changed to include stillbirths (ie, all births [1.8%-22.3%] and fetuses alive at the onset of labor [3.7%-38.2%]) or exclude early deaths and limited to births surviving at least 12 hours (50.0%-77.8%). Similar trends were seen for infants born at 23 weeks' gestation. Variation diminished considerably at 24 and 25 weeks' gestation. CONCLUSIONS: International variation in neonatal survival rates at 22 to 23 weeks' gestation diminished considerably when including stillbirths in the denominator, revealing the variation arises in part from differences in the proportion of births reported as live births, which itself is closely connected to the provision of active care.

Funding

In this article, we present independent research funded by the National Institute for Health Research. Dr Smith is funded by a National Institute for Health Research Career Development Fellowship. Dr Morisaki is funded by the Ministry of Health, Labour, and Welfare of Japan (H28-ICT-001), the Japan Society for the Promotion of Science (26870889 and 17K19868), and an Uehara Memorial Foundation research grant. Data for the United Kingdom were provided by the Maternal, Newborn, and Infant Clinical Outcome Review Programme, which is led by Mothers and Babies: Reducing Risk Through Audits and Confidential Enquiries Across the United Kingdom and funded by the National Health System England, the National Health System Wales, the Health and Social Care Division of the Scottish Government, the Northern Ireland Department of Health, and the states of Jersey, Guernsey, and the Isle of Man.

History

Citation

Pediatrics, 2018, 142 (1), e20173324

Author affiliation

/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Health Sciences

Version

  • AM (Accepted Manuscript)

Published in

Pediatrics

Publisher

American Academy of Pediatrics

issn

0031-4005

eissn

1098-4275

Acceptance date

2018-04-09

Copyright date

2018

Available date

2019-07-02

Publisher version

http://pediatrics.aappublications.org/content/142/1/e20173324

Notes

The file associated with this record is under embargo until 12 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.

Language

en

Usage metrics

    University of Leicester Publications

    Categories

    No categories selected

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC